share_log

Why We're Not Concerned About Aehr Test Systems' (NASDAQ:AEHR) Share Price

Why We're Not Concerned About Aehr Test Systems' (NASDAQ:AEHR) Share Price

爲甚麼我們不擔心 Aehr Test Systems(納斯達克股票代碼:AEHR)的股價
Simply Wall St ·  2023/05/19 20:18

With a price-to-earnings (or "P/E") ratio of 63.5x Aehr Test Systems (NASDAQ:AEHR) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 14x and even P/E's lower than 7x are not unusual. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.

市盈率(或 “市盈率”)爲63.5倍 Aehr 測試系統 納斯達克股票代碼:AEHR)目前可能發出了非常看跌的信號,因爲美國將近一半的公司的市盈率低於14倍,即使市盈率低於7倍也並不罕見。但是,市盈率可能相當高是有原因的,需要進一步調查以確定其是否合理。

Aehr Test Systems certainly has been doing a great job lately as it's been growing earnings at a really rapid pace. The P/E is probably high because investors think this strong earnings growth will be enough to outperform the broader market in the near future. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.

Aehr Test Systems最近無疑做得很好,因爲它的收益增長速度非常快。市盈率可能很高,因爲投資者認爲這種強勁的收益增長足以在不久的將來跑贏整個市場。你真的希望如此,否則你將無緣無故地付出相當高的代價。

View our latest analysis for Aehr Test Systems

查看我們對 Aehr 測試系統的最新分析

pe-multiple-vs-industry
NasdaqCM:AEHR Price to Earnings Ratio vs Industry May 19th 2023
Nasdaqcm:AEHR 市盈率與行業的比率 2023 年 5 月 19 日
Want the full picture on earnings, revenue and cash flow for the company? Then our
想全面瞭解公司的收益、收入和現金流嗎?然後我們的
free
免費的
report on Aehr Test Systems will help you shine a light on its historical performance.
關於 Aehr Test Systems 的報告將幫助你揭示其歷史表現。

What Are Growth Metrics Telling Us About The High P/E?

關於高市盈率,增長指標告訴我們甚麼?

In order to justify its P/E ratio, Aehr Test Systems would need to produce outstanding growth well in excess of the market.

爲了證明其市盈率的合理性,Aehr Test Systems需要實現遠遠超過市場的出色增長。

Retrospectively, the last year delivered an exceptional 210% gain to the company's bottom line. The strong recent performance means it was also able to grow EPS by 5,829% in total over the last three years. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

回顧過去,去年公司利潤大幅增長了210%。最近的強勁表現意味着在過去三年中,它的每股收益總額也增長了5,829%。因此,股東們可能會對這些中期收益增長率表示歡迎。

Weighing that recent medium-term earnings trajectory against the broader market's one-year forecast for expansion of 5.9% shows it's noticeably more attractive on an annualised basis.

將最近的中期收益軌跡與整個市場對5.9%的擴張一年預測進行權衡,可以看出,按年計算,它的吸引力明顯更大。

In light of this, it's understandable that Aehr Test Systems' P/E sits above the majority of other companies. Presumably shareholders aren't keen to offload something they believe will continue to outmanoeuvre the bourse.

有鑑於此,可以理解Aehr Test Systems的市盈率高於大多數其他公司。據推測,股東們並不熱衷於拋售他們認爲會繼續超越交易所的東西。

The Final Word

最後一句話

While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.

雖然市盈率不應該是決定你是否買入股票的決定性因素,但它是衡量收益預期的有力晴雨表。

We've established that Aehr Test Systems maintains its high P/E on the strength of its recent three-year growth being higher than the wider market forecast, as expected. Right now shareholders are comfortable with the P/E as they are quite confident earnings aren't under threat. If recent medium-term earnings trends continue, it's hard to see the share price falling strongly in the near future under these circumstances.

我們已經確定,正如預期的那樣,Aehr Test Systems保持了高市盈率,這是因爲其最近三年的增長高於更廣泛的市場預期。目前,股東們對市盈率感到滿意,因爲他們非常有信心收益不會受到威脅。如果最近的中期收益趨勢繼續下去,在這種情況下,很難看到股價在不久的將來會強勁下跌。

It's always necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Aehr Test Systems (at least 1 which doesn't sit too well with us), and understanding these should be part of your investment process.

始終需要考慮永遠存在的投資風險幽靈。 我們已經在 Aehr 測試系統中發現了 4 個警告信號 (至少 1 個對我們來說不太合適),瞭解這些應該是你投資過程的一部分。

If these risks are making you reconsider your opinion on Aehr Test Systems, explore our interactive list of high quality stocks to get an idea of what else is out there.

如果這些 風險讓你重新考慮自己對 Aehr Test Systems 的看法,瀏覽我們的高品質股票互動清單,瞭解還有甚麼。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?擔心內容嗎? 取得聯繫 直接和我們在一起。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。 我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。 它不構成買入或賣出任何股票的建議,也沒有考慮您的目標或財務狀況。我們的目標是爲您提供由基本面數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。簡而言之,華爾街在上述任何股票中都沒有頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論